Global Oral Transmucosal Drugs Supply, Demand and Key Producers, 2024-2030
Page: 150
Published Date: 02 Mar 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Oral Transmucosal Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Oral Transmucosal Drugs
This report studies the global Oral Transmucosal Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oral Transmucosal Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oral Transmucosal Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oral Transmucosal Drugs total production and demand, 2019-2030, (K Units)
Global Oral Transmucosal Drugs total production value, 2019-2030, (USD Million)
Global Oral Transmucosal Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Oral Transmucosal Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Oral Transmucosal Drugs domestic production, consumption, key domestic manufacturers and share
Global Oral Transmucosal Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Oral Transmucosal Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Oral Transmucosal Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Oral Transmucosal Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include LTS Lohmann Therapie-Systeme AG, Soligenix, ZIM Laboratories Limited, Access Pharmaceutical Inc., C.L Pharm, Cure Pharmaceutical, Aquestive Therapeutics, Inc., NAL Pharma and IntelGenx Corp., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oral Transmucosal Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Oral Transmucosal Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Oral Transmucosal Drugs Market, Segmentation by Type
Tablets
Films
Liquid Spray
Gels
Others
Global Oral Transmucosal Drugs Market, Segmentation by Application
Cardiovascular Disorders
Acute Pain Managements
Diabetes
Others
Companies Profiled:
LTS Lohmann Therapie-Systeme AG
Soligenix
ZIM Laboratories Limited
Access Pharmaceutical Inc.
C.L Pharm
Cure Pharmaceutical
Aquestive Therapeutics, Inc.
NAL Pharma
IntelGenx Corp.
Eisai Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
GlaxoSmithKline plc
Viatris
Bristol-Myers Squibb Company
Key Questions Answered
1. How big is the global Oral Transmucosal Drugs market?
2. What is the demand of the global Oral Transmucosal Drugs market?
3. What is the year over year growth of the global Oral Transmucosal Drugs market?
4. What is the production and production value of the global Oral Transmucosal Drugs market?
5. Who are the key producers in the global Oral Transmucosal Drugs market?
Table of Contents
1 Supply Summary
1.1 Oral Transmucosal Drugs Introduction
1.2 World Oral Transmucosal Drugs Supply & Forecast
1.2.1 World Oral Transmucosal Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World Oral Transmucosal Drugs Production (2019-2030)
1.2.3 World Oral Transmucosal Drugs Pricing Trends (2019-2030)
1.3 World Oral Transmucosal Drugs Production by Region (Based on Production Site)
1.3.1 World Oral Transmucosal Drugs Production Value by Region (2019-2030)
1.3.2 World Oral Transmucosal Drugs Production by Region (2019-2030)
1.3.3 World Oral Transmucosal Drugs Average Price by Region (2019-2030)
1.3.4 North America Oral Transmucosal Drugs Production (2019-2030)
1.3.5 Europe Oral Transmucosal Drugs Production (2019-2030)
1.3.6 China Oral Transmucosal Drugs Production (2019-2030)
1.3.7 Japan Oral Transmucosal Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oral Transmucosal Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oral Transmucosal Drugs Major Market Trends
2.1 World Oral Transmucosal Drugs Demand (2019-2030)
2.2 World Oral Transmucosal Drugs Consumption by Region
2.2.1 World Oral Transmucosal Drugs Consumption by Region (2019-2024)
2.2.2 World Oral Transmucosal Drugs Consumption Forecast by Region (2025-2030)
2.3 United States Oral Transmucosal Drugs Consumption (2019-2030)
2.4 China Oral Transmucosal Drugs Consumption (2019-2030)
2.5 Europe Oral Transmucosal Drugs Consumption (2019-2030)
2.6 Japan Oral Transmucosal Drugs Consumption (2019-2030)
2.7 South Korea Oral Transmucosal Drugs Consumption (2019-2030)
2.8 ASEAN Oral Transmucosal Drugs Consumption (2019-2030)
2.9 India Oral Transmucosal Drugs Consumption (2019-2030)
3.1 World Oral Transmucosal Drugs Production Value by Manufacturer (2019-2024)
3.2 World Oral Transmucosal Drugs Production by Manufacturer (2019-2024)
3.3 World Oral Transmucosal Drugs Average Price by Manufacturer (2019-2024)
3.4 Oral Transmucosal Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oral Transmucosal Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oral Transmucosal Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for Oral Transmucosal Drugs in 2023
3.6 Oral Transmucosal Drugs Market: Overall Company Footprint Analysis
3.6.1 Oral Transmucosal Drugs Market: Region Footprint
3.6.2 Oral Transmucosal Drugs Market: Company Product Type Footprint
3.6.3 Oral Transmucosal Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Oral Transmucosal Drugs Production Value Comparison
4.1.1 United States VS China: Oral Transmucosal Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Oral Transmucosal Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Oral Transmucosal Drugs Production Comparison
4.2.1 United States VS China: Oral Transmucosal Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Oral Transmucosal Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Oral Transmucosal Drugs Consumption Comparison
4.3.1 United States VS China: Oral Transmucosal Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Oral Transmucosal Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Oral Transmucosal Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Oral Transmucosal Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oral Transmucosal Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers Oral Transmucosal Drugs Production (2019-2024)
4.5 China Based Oral Transmucosal Drugs Manufacturers and Market Share
4.5.1 China Based Oral Transmucosal Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oral Transmucosal Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers Oral Transmucosal Drugs Production (2019-2024)
4.6 Rest of World Based Oral Transmucosal Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Oral Transmucosal Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oral Transmucosal Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Oral Transmucosal Drugs Production (2019-2024)
5.1 World Oral Transmucosal Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Tablets
5.2.2 Films
5.2.3 Liquid Spray
5.2.4 Gels
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Oral Transmucosal Drugs Production by Type (2019-2030)
5.3.2 World Oral Transmucosal Drugs Production Value by Type (2019-2030)
5.3.3 World Oral Transmucosal Drugs Average Price by Type (2019-2030)
6.1 World Oral Transmucosal Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Cardiovascular Disorders
6.2.2 Acute Pain Managements
6.2.3 Diabetes
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Oral Transmucosal Drugs Production by Application (2019-2030)
6.3.2 World Oral Transmucosal Drugs Production Value by Application (2019-2030)
6.3.3 World Oral Transmucosal Drugs Average Price by Application (2019-2030)
7.1 LTS Lohmann Therapie-Systeme AG
7.1.1 LTS Lohmann Therapie-Systeme AG Details
7.1.2 LTS Lohmann Therapie-Systeme AG Major Business
7.1.3 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product and Services
7.1.4 LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 LTS Lohmann Therapie-Systeme AG Recent Developments/Updates
7.1.6 LTS Lohmann Therapie-Systeme AG Competitive Strengths & Weaknesses
7.2 Soligenix
7.2.1 Soligenix Details
7.2.2 Soligenix Major Business
7.2.3 Soligenix Oral Transmucosal Drugs Product and Services
7.2.4 Soligenix Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Soligenix Recent Developments/Updates
7.2.6 Soligenix Competitive Strengths & Weaknesses
7.3 ZIM Laboratories Limited
7.3.1 ZIM Laboratories Limited Details
7.3.2 ZIM Laboratories Limited Major Business
7.3.3 ZIM Laboratories Limited Oral Transmucosal Drugs Product and Services
7.3.4 ZIM Laboratories Limited Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 ZIM Laboratories Limited Recent Developments/Updates
7.3.6 ZIM Laboratories Limited Competitive Strengths & Weaknesses
7.4 Access Pharmaceutical Inc.
7.4.1 Access Pharmaceutical Inc. Details
7.4.2 Access Pharmaceutical Inc. Major Business
7.4.3 Access Pharmaceutical Inc. Oral Transmucosal Drugs Product and Services
7.4.4 Access Pharmaceutical Inc. Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Access Pharmaceutical Inc. Recent Developments/Updates
7.4.6 Access Pharmaceutical Inc. Competitive Strengths & Weaknesses
7.5 C.L Pharm
7.5.1 C.L Pharm Details
7.5.2 C.L Pharm Major Business
7.5.3 C.L Pharm Oral Transmucosal Drugs Product and Services
7.5.4 C.L Pharm Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 C.L Pharm Recent Developments/Updates
7.5.6 C.L Pharm Competitive Strengths & Weaknesses
7.6 Cure Pharmaceutical
7.6.1 Cure Pharmaceutical Details
7.6.2 Cure Pharmaceutical Major Business
7.6.3 Cure Pharmaceutical Oral Transmucosal Drugs Product and Services
7.6.4 Cure Pharmaceutical Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Cure Pharmaceutical Recent Developments/Updates
7.6.6 Cure Pharmaceutical Competitive Strengths & Weaknesses
7.7 Aquestive Therapeutics, Inc.
7.7.1 Aquestive Therapeutics, Inc. Details
7.7.2 Aquestive Therapeutics, Inc. Major Business
7.7.3 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product and Services
7.7.4 Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Aquestive Therapeutics, Inc. Recent Developments/Updates
7.7.6 Aquestive Therapeutics, Inc. Competitive Strengths & Weaknesses
7.8 NAL Pharma
7.8.1 NAL Pharma Details
7.8.2 NAL Pharma Major Business
7.8.3 NAL Pharma Oral Transmucosal Drugs Product and Services
7.8.4 NAL Pharma Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 NAL Pharma Recent Developments/Updates
7.8.6 NAL Pharma Competitive Strengths & Weaknesses
7.9 IntelGenx Corp.
7.9.1 IntelGenx Corp. Details
7.9.2 IntelGenx Corp. Major Business
7.9.3 IntelGenx Corp. Oral Transmucosal Drugs Product and Services
7.9.4 IntelGenx Corp. Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 IntelGenx Corp. Recent Developments/Updates
7.9.6 IntelGenx Corp. Competitive Strengths & Weaknesses
7.10 Eisai Co., Ltd.
7.10.1 Eisai Co., Ltd. Details
7.10.2 Eisai Co., Ltd. Major Business
7.10.3 Eisai Co., Ltd. Oral Transmucosal Drugs Product and Services
7.10.4 Eisai Co., Ltd. Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Eisai Co., Ltd. Recent Developments/Updates
7.10.6 Eisai Co., Ltd. Competitive Strengths & Weaknesses
7.11 Otsuka Pharmaceutical Co., Ltd.
7.11.1 Otsuka Pharmaceutical Co., Ltd. Details
7.11.2 Otsuka Pharmaceutical Co., Ltd. Major Business
7.11.3 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product and Services
7.11.4 Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
7.11.6 Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.12 Teva Pharmaceutical Industries Ltd.
7.12.1 Teva Pharmaceutical Industries Ltd. Details
7.12.2 Teva Pharmaceutical Industries Ltd. Major Business
7.12.3 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product and Services
7.12.4 Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
7.12.6 Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.13 GlaxoSmithKline plc
7.13.1 GlaxoSmithKline plc Details
7.13.2 GlaxoSmithKline plc Major Business
7.13.3 GlaxoSmithKline plc Oral Transmucosal Drugs Product and Services
7.13.4 GlaxoSmithKline plc Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 GlaxoSmithKline plc Recent Developments/Updates
7.13.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.14 Viatris
7.14.1 Viatris Details
7.14.2 Viatris Major Business
7.14.3 Viatris Oral Transmucosal Drugs Product and Services
7.14.4 Viatris Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.14.5 Viatris Recent Developments/Updates
7.14.6 Viatris Competitive Strengths & Weaknesses
7.15 Bristol-Myers Squibb Company
7.15.1 Bristol-Myers Squibb Company Details
7.15.2 Bristol-Myers Squibb Company Major Business
7.15.3 Bristol-Myers Squibb Company Oral Transmucosal Drugs Product and Services
7.15.4 Bristol-Myers Squibb Company Oral Transmucosal Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.15.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.15.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
8.1 Oral Transmucosal Drugs Industry Chain
8.2 Oral Transmucosal Drugs Upstream Analysis
8.2.1 Oral Transmucosal Drugs Core Raw Materials
8.2.2 Main Manufacturers of Oral Transmucosal Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Oral Transmucosal Drugs Production Mode
8.6 Oral Transmucosal Drugs Procurement Model
8.7 Oral Transmucosal Drugs Industry Sales Model and Sales Channels
8.7.1 Oral Transmucosal Drugs Sales Model
8.7.2 Oral Transmucosal Drugs Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Oral Transmucosal Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Oral Transmucosal Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World Oral Transmucosal Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World Oral Transmucosal Drugs Production Value Market Share by Region (2019-2024)
Table 5. World Oral Transmucosal Drugs Production Value Market Share by Region (2025-2030)
Table 6. World Oral Transmucosal Drugs Production by Region (2019-2024) & (K Units)
Table 7. World Oral Transmucosal Drugs Production by Region (2025-2030) & (K Units)
Table 8. World Oral Transmucosal Drugs Production Market Share by Region (2019-2024)
Table 9. World Oral Transmucosal Drugs Production Market Share by Region (2025-2030)
Table 10. World Oral Transmucosal Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Oral Transmucosal Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Oral Transmucosal Drugs Major Market Trends
Table 13. World Oral Transmucosal Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Oral Transmucosal Drugs Consumption by Region (2019-2024) & (K Units)
Table 15. World Oral Transmucosal Drugs Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Oral Transmucosal Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Oral Transmucosal Drugs Producers in 2023
Table 18. World Oral Transmucosal Drugs Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Oral Transmucosal Drugs Producers in 2023
Table 20. World Oral Transmucosal Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Oral Transmucosal Drugs Company Evaluation Quadrant
Table 22. World Oral Transmucosal Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Oral Transmucosal Drugs Production Site of Key Manufacturer
Table 24. Oral Transmucosal Drugs Market: Company Product Type Footprint
Table 25. Oral Transmucosal Drugs Market: Company Product Application Footprint
Table 26. Oral Transmucosal Drugs Competitive Factors
Table 27. Oral Transmucosal Drugs New Entrant and Capacity Expansion Plans
Table 28. Oral Transmucosal Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Oral Transmucosal Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Oral Transmucosal Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Oral Transmucosal Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Oral Transmucosal Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Oral Transmucosal Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Oral Transmucosal Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Oral Transmucosal Drugs Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Oral Transmucosal Drugs Production Market Share (2019-2024)
Table 37. China Based Oral Transmucosal Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Oral Transmucosal Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Oral Transmucosal Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Oral Transmucosal Drugs Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Oral Transmucosal Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based Oral Transmucosal Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Oral Transmucosal Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Oral Transmucosal Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Oral Transmucosal Drugs Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Oral Transmucosal Drugs Production Market Share (2019-2024)
Table 47. World Oral Transmucosal Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Oral Transmucosal Drugs Production by Type (2019-2024) & (K Units)
Table 49. World Oral Transmucosal Drugs Production by Type (2025-2030) & (K Units)
Table 50. World Oral Transmucosal Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World Oral Transmucosal Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World Oral Transmucosal Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Oral Transmucosal Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Oral Transmucosal Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Oral Transmucosal Drugs Production by Application (2019-2024) & (K Units)
Table 56. World Oral Transmucosal Drugs Production by Application (2025-2030) & (K Units)
Table 57. World Oral Transmucosal Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World Oral Transmucosal Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World Oral Transmucosal Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Oral Transmucosal Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. LTS Lohmann Therapie-Systeme AG Basic Information, Manufacturing Base and Competitors
Table 62. LTS Lohmann Therapie-Systeme AG Major Business
Table 63. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Product and Services
Table 64. LTS Lohmann Therapie-Systeme AG Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. LTS Lohmann Therapie-Systeme AG Recent Developments/Updates
Table 66. LTS Lohmann Therapie-Systeme AG Competitive Strengths & Weaknesses
Table 67. Soligenix Basic Information, Manufacturing Base and Competitors
Table 68. Soligenix Major Business
Table 69. Soligenix Oral Transmucosal Drugs Product and Services
Table 70. Soligenix Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Soligenix Recent Developments/Updates
Table 72. Soligenix Competitive Strengths & Weaknesses
Table 73. ZIM Laboratories Limited Basic Information, Manufacturing Base and Competitors
Table 74. ZIM Laboratories Limited Major Business
Table 75. ZIM Laboratories Limited Oral Transmucosal Drugs Product and Services
Table 76. ZIM Laboratories Limited Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. ZIM Laboratories Limited Recent Developments/Updates
Table 78. ZIM Laboratories Limited Competitive Strengths & Weaknesses
Table 79. Access Pharmaceutical Inc. Basic Information, Manufacturing Base and Competitors
Table 80. Access Pharmaceutical Inc. Major Business
Table 81. Access Pharmaceutical Inc. Oral Transmucosal Drugs Product and Services
Table 82. Access Pharmaceutical Inc. Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Access Pharmaceutical Inc. Recent Developments/Updates
Table 84. Access Pharmaceutical Inc. Competitive Strengths & Weaknesses
Table 85. C.L Pharm Basic Information, Manufacturing Base and Competitors
Table 86. C.L Pharm Major Business
Table 87. C.L Pharm Oral Transmucosal Drugs Product and Services
Table 88. C.L Pharm Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. C.L Pharm Recent Developments/Updates
Table 90. C.L Pharm Competitive Strengths & Weaknesses
Table 91. Cure Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Cure Pharmaceutical Major Business
Table 93. Cure Pharmaceutical Oral Transmucosal Drugs Product and Services
Table 94. Cure Pharmaceutical Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Cure Pharmaceutical Recent Developments/Updates
Table 96. Cure Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Aquestive Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Aquestive Therapeutics, Inc. Major Business
Table 99. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Product and Services
Table 100. Aquestive Therapeutics, Inc. Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Aquestive Therapeutics, Inc. Recent Developments/Updates
Table 102. Aquestive Therapeutics, Inc. Competitive Strengths & Weaknesses
Table 103. NAL Pharma Basic Information, Manufacturing Base and Competitors
Table 104. NAL Pharma Major Business
Table 105. NAL Pharma Oral Transmucosal Drugs Product and Services
Table 106. NAL Pharma Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. NAL Pharma Recent Developments/Updates
Table 108. NAL Pharma Competitive Strengths & Weaknesses
Table 109. IntelGenx Corp. Basic Information, Manufacturing Base and Competitors
Table 110. IntelGenx Corp. Major Business
Table 111. IntelGenx Corp. Oral Transmucosal Drugs Product and Services
Table 112. IntelGenx Corp. Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. IntelGenx Corp. Recent Developments/Updates
Table 114. IntelGenx Corp. Competitive Strengths & Weaknesses
Table 115. Eisai Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 116. Eisai Co., Ltd. Major Business
Table 117. Eisai Co., Ltd. Oral Transmucosal Drugs Product and Services
Table 118. Eisai Co., Ltd. Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Eisai Co., Ltd. Recent Developments/Updates
Table 120. Eisai Co., Ltd. Competitive Strengths & Weaknesses
Table 121. Otsuka Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 122. Otsuka Pharmaceutical Co., Ltd. Major Business
Table 123. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Product and Services
Table 124. Otsuka Pharmaceutical Co., Ltd. Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Otsuka Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 126. Otsuka Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 127. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 128. Teva Pharmaceutical Industries Ltd. Major Business
Table 129. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Product and Services
Table 130. Teva Pharmaceutical Industries Ltd. Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 132. Teva Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 133. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 134. GlaxoSmithKline plc Major Business
Table 135. GlaxoSmithKline plc Oral Transmucosal Drugs Product and Services
Table 136. GlaxoSmithKline plc Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. GlaxoSmithKline plc Recent Developments/Updates
Table 138. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 139. Viatris Basic Information, Manufacturing Base and Competitors
Table 140. Viatris Major Business
Table 141. Viatris Oral Transmucosal Drugs Product and Services
Table 142. Viatris Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 143. Viatris Recent Developments/Updates
Table 144. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 145. Bristol-Myers Squibb Company Major Business
Table 146. Bristol-Myers Squibb Company Oral Transmucosal Drugs Product and Services
Table 147. Bristol-Myers Squibb Company Oral Transmucosal Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 148. Global Key Players of Oral Transmucosal Drugs Upstream (Raw Materials)
Table 149. Oral Transmucosal Drugs Typical Customers
Table 150. Oral Transmucosal Drugs Typical Distributors
List of Figure
Figure 1. Oral Transmucosal Drugs Picture
Figure 2. World Oral Transmucosal Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Oral Transmucosal Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Oral Transmucosal Drugs Production (2019-2030) & (K Units)
Figure 5. World Oral Transmucosal Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World Oral Transmucosal Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World Oral Transmucosal Drugs Production Market Share by Region (2019-2030)
Figure 8. North America Oral Transmucosal Drugs Production (2019-2030) & (K Units)
Figure 9. Europe Oral Transmucosal Drugs Production (2019-2030) & (K Units)
Figure 10. China Oral Transmucosal Drugs Production (2019-2030) & (K Units)
Figure 11. Japan Oral Transmucosal Drugs Production (2019-2030) & (K Units)
Figure 12. Oral Transmucosal Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Oral Transmucosal Drugs Consumption (2019-2030) & (K Units)
Figure 15. World Oral Transmucosal Drugs Consumption Market Share by Region (2019-2030)
Figure 16. United States Oral Transmucosal Drugs Consumption (2019-2030) & (K Units)
Figure 17. China Oral Transmucosal Drugs Consumption (2019-2030) & (K Units)
Figure 18. Europe Oral Transmucosal Drugs Consumption (2019-2030) & (K Units)
Figure 19. Japan Oral Transmucosal Drugs Consumption (2019-2030) & (K Units)
Figure 20. South Korea Oral Transmucosal Drugs Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Oral Transmucosal Drugs Consumption (2019-2030) & (K Units)
Figure 22. India Oral Transmucosal Drugs Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Oral Transmucosal Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Oral Transmucosal Drugs Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Oral Transmucosal Drugs Markets in 2023
Figure 26. United States VS China: Oral Transmucosal Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Oral Transmucosal Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Oral Transmucosal Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Oral Transmucosal Drugs Production Market Share 2023
Figure 30. China Based Manufacturers Oral Transmucosal Drugs Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Oral Transmucosal Drugs Production Market Share 2023
Figure 32. World Oral Transmucosal Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Oral Transmucosal Drugs Production Value Market Share by Type in 2023
Figure 34. Tablets
Figure 35. Films
Figure 36. Liquid Spray
Figure 37. Gels
Figure 38. Others
Figure 39. World Oral Transmucosal Drugs Production Market Share by Type (2019-2030)
Figure 40. World Oral Transmucosal Drugs Production Value Market Share by Type (2019-2030)
Figure 41. World Oral Transmucosal Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 42. World Oral Transmucosal Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 43. World Oral Transmucosal Drugs Production Value Market Share by Application in 2023
Figure 44. Cardiovascular Disorders
Figure 45. Acute Pain Managements
Figure 46. Diabetes
Figure 47. Others
Figure 48. World Oral Transmucosal Drugs Production Market Share by Application (2019-2030)
Figure 49. World Oral Transmucosal Drugs Production Value Market Share by Application (2019-2030)
Figure 50. World Oral Transmucosal Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 51. Oral Transmucosal Drugs Industry Chain
Figure 52. Oral Transmucosal Drugs Procurement Model
Figure 53. Oral Transmucosal Drugs Sales Model
Figure 54. Oral Transmucosal Drugs Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
LTS Lohmann Therapie-Systeme AG Soligenix ZIM Laboratories Limited Access Pharmaceutical Inc. C.L Pharm Cure Pharmaceutical Aquestive Therapeutics, Inc. NAL Pharma IntelGenx Corp. Eisai Co., Ltd. Otsuka Pharmaceutical Co., Ltd. Teva Pharmaceutical Industries Ltd. GlaxoSmithKline plc Viatris Bristol-Myers Squibb Company
Related Reports
22 Jun 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
